Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dingell Import Safety Bill Includes User Fees To Fund Foreign Inspections

This article was originally published in The Tan Sheet

Executive Summary

Legislation introduced by House Energy and Commerce Committee members Sept. 20 to improve food and drug import safety would authorize user fees to be directed at hiring more FDA inspectors and other officials for import analysis in the U.S. and abroad

You may also be interested in...



Country-Of-Origin Labeling Would Add Costs But No Consumer Benefit – CRN

Requiring country-of-origin labeling for dietary supplements would be redundant with good manufacturing practices and could raise prices without benefiting consumers, according to the Council for Responsible Nutrition

Country-Of-Origin Labeling Would Add Costs But No Consumer Benefit – CRN

Requiring country-of-origin labeling for dietary supplements would be redundant with good manufacturing practices and could raise prices without benefiting consumers, according to the Council for Responsible Nutrition

Country-Of-Origin Labeling Would Add Costs But No Consumer Benefit – CRN

Requiring country-of-origin labeling for dietary supplements would be redundant with good manufacturing practices and could raise prices without benefiting consumers, according to the Council for Responsible Nutrition

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS100928

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel